SEC Filings

Filing date	Form	Description	View
03/09/16	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001179110-16-021464.pdf 0001179110-16-021464.rtf 0001179110-16-021464.xls
03/09/16	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001179110-16-021466.pdf 0001179110-16-021466.rtf 0001179110-16-021466.xls
02/25/16	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-16-100008.pdf 0001104659-16-100008.rtf 0001104659-16-100008.xls
02/23/16	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-019956.pdf 0001179110-16-019956.rtf 0001179110-16-019956.xls
02/23/16	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-019964.pdf 0001179110-16-019964.rtf 0001179110-16-019964.xls
02/23/16	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-019957.pdf 0001179110-16-019957.rtf 0001179110-16-019957.xls
02/23/16	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-019958.pdf 0001179110-16-019958.rtf 0001179110-16-019958.xls
02/23/16	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-019969.pdf 0001179110-16-019969.rtf 0001179110-16-019969.xls
02/23/16	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-019960.pdf 0001179110-16-019960.rtf 0001179110-16-019960.xls
02/23/16	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-16-019967.pdf 0001179110-16-019967.rtf 0001179110-16-019967.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.